1
Lipids play an important role in dermatitis as inflammatory mediators and as cell signaling molecules, particularly phospholipids and free fatty acids. Alterations in the lipid composition can lead to diminished barrier function of the skin and are associated with diseases like atopic dermatitis. SHARPIN-deficient cpdm mice develop a chronic dermatitis with similarities to atopic dermatitis in humans and present changes in their epidermis lipids profiles. To gain knowledge of the localization of these changes, we used Matrix-Assisted Laser Desorption Ionization MALDI MSI (mass spectrometry imaging) to localize discriminative lipids from cpdm mice compared to wild-type littermates. These lipids may be of diagnostic and clinical utility in atopic dermatitis in humans and domestic animals. Introduction Methods Figure 2. Detection of free fatty acids in cpdm and WT samples. (A) MSI of WT and cpdm skin samples of 5 weeks old mice showing relative intensities of lipid ions in skin cross sections. Docosatetraenoic acid and araquidonic acid results appear increased in cpdm samples compared to WT, which is agreement with MRM- profiling results. (B) Distribution of free fatty acids in the epidermis by MRM-profiling. Free fatty acids identified by carbon chain length and degree of unsaturation were analyzed in negative ion mode by SIM. The relative amounts of arachidonic acid (20:4) and docosatetraenoic acid (22:4) were increased in cpdm mice. Bars represent the means + SE of the samples. *significantly different at p < 0.05 following multiple comparison correction. Cholesterol sulfate Variations in skin lipid content in a mouse model of dermatitis analyzed by Mass Spectrometry Imaging Jackeline Franco 1,2 , Christina Ferreira 2 , Bindesh Shrestha 3 , John P. Sundberg 4 , Harm HogenEsch 1,5 * 1 Department of Comparative Pathobiology, Purdue University, West Lafayette, IN; 2 Metabolite Profiling Facility, Bindley Bioscience Center, Purdue University, West Lafayette, IN; 3 Waters Corporation, Beverly, MA; 4 The Jackson Laboratory, Bar Harbor, ME; 5 Purdue Institute of Inflammation, Immunology and Infectious Diseases, Purdue University, West Lafayette, IN. *[email protected] Phospholipid Mass spectrometry imaging identifies highly discriminative lipids in a mouse model of dermatitis. MS imaging was successful at providing the spatial location of lipids. MS imaging results were in agreement with results from an agnostic (i.e. comprehensive and not dependent on database ID) mass- spectrometry strategy for biomarker discovery termed multiple- reaction monitoring (MRM)-profiling. The identification and location of these lipid changes may represent a molecular tool to assess inflammation and therapeutic outcomes of skin barrier improvement treatments. Conclusions Acknowledgments These studies were supported in part by grants from the National Institutes of Health (AR049288), the Purdue Institute for Inflammation, Immunology and Infectious Diseases, Waters corporation and COLCIENCIAS, Colombia. The authors thank Dr. Fangjia Lu for his helpful assistance. B A Free Fatty Acids Figure 3. Detection of cholesterol sulfate in WT and cpdm samples. (A) MSI of WT and cpdm skin samples of 8 weeks old mice showing cholesterol sulfate (red) restricted to the epidermis and ubiquitous PI(38:4) (green). (B) H&E stained cross section of WT and cpdm skin samples. (C) Relative amounts of cholesterol sulfate monitored by MRM-profiling of the epidermis of 8 week old mice. The relative amounts of cholesterol sulfate were decreased in cpdm mice. Bars represent the means of 18 samples *P = 0.0058 Sharpin cpdm WT Mass Spectrometry Imaging (MSI) workflow Epidermis Dermis * Snap frozen in carboxymethylcellulose 10μm cross section in glass slides Skin samples 5 and 8 week old females WT/Cpdm (n=4) MSI data was compared with data acquired by MRM-profiling using ESI-MS MSI A Multivariate statistical analysis MRM methods Screening (n=36) Free Fatty Acids (FFA) Phospholipids (PC, PE, PS, PI) Discovery Testing set (n=15) Analysis Lipid extraction by Bligh and Dyer method Epidermis samples 8 week old females WT/Cpdm N=36 MRM-Profiling: Mass spectrometry approach A A B Linoleic acid (18:2) 5 weeks old Epidermis Dermis Araquidonic Acid (20:4) Epidermis Dermis 5 weeks old Epidermis Dermis Docosahexaenoic acid (22:6) 5 weeks old Epidermis Dermis Docosatetraenoic acid (22:4) 5 weeks old PE(36:1)/PC (33:1)/pPC(34:0) [M-H] - m/z 745.8 5 weeks old Figure 4. Detection of phospholipid in WT and cpdm samples. (A) MSI of WT and cpdm skin samples of 8 week old mice showing [M-H]- m/z 745.8 with tentative attribution of PE(36:1)/PC (33:1)/pPC(34:0) increased in cpdm sample compared to WT. (B) Relative amounts of [M-H]- m/z 745.8 monitored by MRM-profiling of the epidermis 8 week old mice. Bars represent the mean of the 18 samples *P <0.001 MALDI imaging information Figure 1. Representation of mass spectrum acquired from cpdm and WT skin samples. Mass spectrum collected from WT and cpdm skin samples showing relative intensities of lipid ions peaks found in skin cross sections. High Resolution mass spectrometry imaging is capable of finding spatial distribution of multiple ions within 1 Da. B C * WT cpdm

MALDI imaging of Skin - Waters Corporation · 2018. 3. 28. · *[email protected] Phospholipid •Mass spectrometry imaging identifies highly discriminative lipids in a mouse model

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

  • • Lipids play an important role in dermatitis as inflammatory mediators and as cell signaling molecules, particularly phospholipids and free fatty acids.

    • Alterations in the lipid composition can lead to diminished barrier function of the skin and are associated with diseases like atopic dermatitis.

    • SHARPIN-deficient cpdm mice develop a chronic dermatitis with similarities to atopic dermatitis in humans and present changes in their epidermis lipids profiles.

    • To gain knowledge of the localization of these changes, we used Matrix-Assisted Laser Desorption Ionization MALDI MSI (mass spectrometry imaging) to localize discriminative lipids from cpdm mice compared to wild-type littermates.

    • These lipids may be of diagnostic and clinical utility in atopic dermatitis in humans and domestic animals.

    Introduction

    Methods

    Figure 2. Detection of free fatty acids in cpdm and WT samples. (A) MSI of WT and cpdm skin samples of 5 weeks old mice showing relative intensities of lipid ions in skin cross sections. Docosatetraenoic acid and araquidonic acid results appear increased in cpdm samples compared to WT, which is agreement with MRM-profiling results. (B) Distribution of free fatty acids in the epidermis by MRM-profiling. Free fatty acids identified by carbon chain length and degree of unsaturation were analyzed in negative ion mode by SIM. The relative amounts of arachidonic acid (20:4) and docosatetraenoic acid (22:4) were increased in cpdm mice. Bars represent the means + SE of the samples. *significantly different at p < 0.05 following multiple comparison correction.

    Cholesterol sulfate

    Variations in skin lipid content in a mouse model of dermatitis analyzed by Mass Spectrometry Imaging

    Jackeline Franco1,2, Christina Ferreira2, Bindesh Shrestha3, John P. Sundberg4, Harm HogenEsch1,5 * 1 Department of Comparative Pathobiology, Purdue University, West Lafayette, IN; 2 Metabolite Profiling Facility, Bindley Bioscience Center, Purdue University, West Lafayette, IN; 3 Waters Corporation, Beverly, MA; 4 The

    Jackson Laboratory, Bar Harbor, ME; 5 Purdue Institute of Inflammation, Immunology and Infectious Diseases, Purdue University, West Lafayette, IN. *[email protected]

    Phospholipid

    • Mass spectrometry imaging identifies highly discriminative lipids in a mouse model of dermatitis.

    • MS imaging was successful at providing the spatial location of lipids. • MS imaging results were in agreement with results from an agnostic

    (i.e. comprehensive and not dependent on database ID) mass-spectrometry strategy for biomarker discovery termed multiple-reaction monitoring (MRM)-profiling.

    • The identification and location of these lipid changes may represent a molecular tool to assess inflammation and therapeutic outcomes of skin barrier improvement treatments.

    Conclusions

    Acknowledgments

    These studies were supported in part by grants from the National Institutes of Health (AR049288), the Purdue Institute for Inflammation, Immunology and Infectious Diseases, Waters corporation and COLCIENCIAS, Colombia. The authors thank Dr. Fangjia Lu for his helpful assistance.

    B A

    Free Fatty Acids

    Figure 3. Detection of cholesterol sulfate in WT and cpdm samples. (A) MSI of WT and cpdm skin samples of 8 weeks old mice showing cholesterol sulfate (red) restricted to the epidermis and ubiquitous PI(38:4) (green). (B) H&E stained cross section of WT and cpdm skin samples. (C) Relative amounts of cholesterol sulfate monitored by MRM-profiling of the epidermis of 8 week old mice. The relative amounts of cholesterol sulfate were decreased in cpdm mice. Bars represent the means of 18 samples *P = 0.0058

    Sharpincpdm WT

    Mass Spectrometry Imaging (MSI) workflow

    Epidermis

    Dermis

    *

    Snap frozen in carboxymethylcellulose

    10µm cross section in glass slides

    Skin samples

    5 and 8 week old females

    WT/Cpdm (n=4)

    MSI data was compared with data acquired by MRM-profiling using ESI-MS

    MSI A Multivariate statistical analysis MRM methods

    Screening (n=36)

    Free Fatty Acids (FFA) Phospholipids (PC, PE, PS, PI)

    Discovery Testing set (n=15)

    Analysis

    Lipid extraction by Bligh and Dyer

    method

    Epidermis samples

    8 week old females WT/Cpdm N=36

    MR

    M-P

    rofi

    ling:

    Mas

    s sp

    ectr

    om

    etry

    ap

    pro

    ach

    A A

    B

    Linoleic acid (18:2)

    5 weeks old

    Epidermis

    Dermis

    Araquidonic Acid (20:4)

    Epidermis

    Dermis

    5 weeks old

    Epidermis

    Dermis

    Docosahexaenoic acid (22:6)

    5 weeks old

    Epidermis

    Dermis

    Docosatetraenoic acid (22:4)

    5 weeks old

    PE(36:1)/PC (33:1)/pPC(34:0) [M-H]- m/z 745.8

    5 weeks old

    Figure 4. Detection of phospholipid in WT and cpdm samples. (A) MSI of WT and cpdm skin samples of 8 week old mice showing [M-H]- m/z 745.8 with tentative attribution of PE(36:1)/PC (33:1)/pPC(34:0) increased in cpdm sample compared to WT. (B) Relative amounts of [M-H]- m/z 745.8 monitored by MRM-profiling of the epidermis 8 week old mice. Bars represent the mean of the 18 samples *P